Prioritizing Genomic Applications for Action by Level of Evidence: A Horizon-Scanning Method

As evidence accumulates on the use of genomic tests and other health-related applications of genomic technologies, decision makers may increasingly seek support in identifying which applications have sufficiently robust evidence to suggest they might be considered for action. As an interim working p...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Pharmacol Ther
Prif Awduron: Dotson, WD, Douglas, MP, Kolor, K, Stewart, AC, Bowen, MS, Gwinn, M, Wulf, A, Anders, HM, Chang, CQ, Clyne, M, Lam, TK, Schully, SD, Marrone, M, Feero, WG, Khoury, MJ
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4689130/
https://ncbi.nlm.nih.gov/pubmed/24398597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2013.226
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg